Discovery and Developmental Therapeutics
The Discovery and Developmental Therapeutics (DDT) Program is the primary driver of discovery and evaluation of novel therapeutic options for patients with cancer at the Winship Cancer Institute.
The DDT Program has developed and recruited expertise focused on four specific interconnected goals: 1) to identify small molecule cancer therapeutics; 2) to translate discoveries in cancer immunology into enhanced therapies; 3) to develop innovative in vivo imaging technologies; and 4) to accelerate targeted therapeutics into clinical trials.
View recent publications by DDT Program members
To find out more about this research program, please contact:
Olga Rivera at firstname.lastname@example.org
Maggie Johns at email@example.com
Cheryl Belton at firstname.lastname@example.org
Learn about Emory University's Cancer Biology Graduate Program by visiting our website.